These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 27412007)

  • 1. Influenza virus A(H1N1)2009 antibody-dependent cellular cytotoxicity in young children prior to the H1N1 pandemic.
    Mesman AW; Westerhuis BM; Ten Hulscher HI; Jacobi RH; de Bruin E; van Beek J; Buisman AM; Koopmans MP; van Binnendijk RS
    J Gen Virol; 2016 Sep; 97(9):2157-2165. PubMed ID: 27412007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age-associated cross-reactive antibody-dependent cellular cytotoxicity toward 2009 pandemic influenza A virus subtype H1N1.
    Jegaskanda S; Laurie KL; Amarasena TH; Winnall WR; Kramski M; De Rose R; Barr IG; Brooks AG; Reading PC; Kent SJ
    J Infect Dis; 2013 Oct; 208(7):1051-61. PubMed ID: 23812238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of baseline age-specific antibody prevalence and incidence of infection to novel influenza A/H1N1 2009.
    Hardelid P; Andrews NJ; Hoschler K; Stanford E; Baguelin M; Waight PA; Zambon M; Miller E
    Health Technol Assess; 2010 Dec; 14(55):115-92. PubMed ID: 21208549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-reactive immunity against influenza viruses in children and adults following 2009 pandemic H1N1 infection.
    Ahmed MS; Jacques LC; Mahallawi W; Ferrara F; Temperton N; Upile N; Vaughan C; Sharma R; Beer H; Hoschler K; McNamara PS; Zhang Q
    Antiviral Res; 2015 Feb; 114():106-12. PubMed ID: 25513756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of pre-existing immunity on the induction of functional cross-reactive anti-hemagglutinin stalk antibodies following vaccination with an AS03 adjuvanted pandemic H1N1 vaccine.
    Tete SM; Jul-Larsen Å; Rostami S; Lunde THF; Søland H; Krammer F; Cox RJ
    Vaccine; 2018 Apr; 36(16):2213-2219. PubMed ID: 29548607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic А/California/07/2009(H1N1) influenza in healthy volunteers.
    Desheva YA; Smolonogina TA; Donina SA; Rudenko LG
    BMC Res Notes; 2015 Apr; 8():136. PubMed ID: 25889924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-reactive influenza-specific antibody-dependent cellular cytotoxicity in intravenous immunoglobulin as a potential therapeutic against emerging influenza viruses.
    Jegaskanda S; Vandenberg K; Laurie KL; Loh L; Kramski M; Winnall WR; Kedzierska K; Rockman S; Kent SJ
    J Infect Dis; 2014 Dec; 210(11):1811-22. PubMed ID: 24916185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation and Protective Ability of Influenza Virus-Specific Antibody-Dependent Cellular Cytotoxicity in Humans Elicited by Vaccination, Natural Infection, and Experimental Challenge.
    Jegaskanda S; Luke C; Hickman HD; Sangster MY; Wieland-Alter WF; McBride JM; Yewdell JW; Wright PF; Treanor J; Rosenberger CM; Subbarao K
    J Infect Dis; 2016 Sep; 214(6):945-52. PubMed ID: 27354365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus.
    Hancock K; Veguilla V; Lu X; Zhong W; Butler EN; Sun H; Liu F; Dong L; DeVos JR; Gargiullo PM; Brammer TL; Cox NJ; Tumpey TM; Katz JM
    N Engl J Med; 2009 Nov; 361(20):1945-52. PubMed ID: 19745214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of preexisting influenza hemagglutination inhibition, complement-dependent lytic, and antibody-dependent cellular cytotoxicity antibodies to the development of clinical illness in a prospective study of A(H1N1)pdm09 Influenza in children.
    Co MD; Terajima M; Thomas SJ; Jarman RG; Rungrojcharoenkit K; Fernandez S; Yoon IK; Buddhari D; Cruz J; Ennis FA
    Viral Immunol; 2014 Oct; 27(8):375-82. PubMed ID: 25141276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serological study of the 2009 pandemic due to influenza A H1N1 in the metropolitan French population.
    Delangue J; Salez N; Ninove L; Kieffer A; Zandotti C; Seston M; Lina B; Nougairede A; Charrel R; Flahault A; de Lamballerie X
    Clin Microbiol Infect; 2012 Feb; 18(2):177-83. PubMed ID: 21635661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of neutralizing antibody and cell-mediated immune responses to pandemic H1N1 2009 influenza virus before and after H1N1 2009 influenza vaccination of elderly subjects and healthcare workers.
    Hsu JP; Phoon MC; Koh GC; Chen MI; Lee VJ; Wu Y; Xie ML; Cheong A; Leo YS; Chow VT
    Int J Infect Dis; 2012 Aug; 16(8):e621-7. PubMed ID: 22704721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of H7N9-Cross-Reactive Antibody-Dependent Cellular Cytotoxicity Antibodies by Human Seasonal Influenza A Viruses that are Directed Toward the Nucleoprotein.
    Jegaskanda S; Co MDT; Cruz J; Subbarao K; Ennis FA; Terajima M
    J Infect Dis; 2017 Mar; 215(5):818-823. PubMed ID: 28011910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-reactive influenza-specific antibody-dependent cellular cytotoxicity antibodies in the absence of neutralizing antibodies.
    Jegaskanda S; Job ER; Kramski M; Laurie K; Isitman G; de Rose R; Winnall WR; Stratov I; Brooks AG; Reading PC; Kent SJ
    J Immunol; 2013 Feb; 190(4):1837-48. PubMed ID: 23319732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study.
    Miller E; Hoschler K; Hardelid P; Stanford E; Andrews N; Zambon M
    Lancet; 2010 Mar; 375(9720):1100-8. PubMed ID: 20096450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sero-immunity and serologic response to pandemic influenza A (H1N1) 2009 virus in Hong Kong.
    Mak GC; Choy PW; Lee WY; Wong AH; Ng KC; Lim W
    J Med Virol; 2010 Nov; 82(11):1809-15. PubMed ID: 20872705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies against swine influenza virus neutralize the pandemic influenza virus A/H1N1.
    Tsukamoto M; Hiroi S; Adachi K; Kato H; Inai M; Konishi I; Tanaka M; Yamamoto R; Sawa M; Handharyani E; Tsukamoto Y
    Mol Med Rep; 2011; 4(2):209-14. PubMed ID: 21468553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of antibody response to the human pandemic influenza H1N1 2009 among patients with influenza-like illness and high risk groups.
    Makkoch J; Payungporn S; Prachayangprecha S; Tantilertcharoen R; Poovorawan Y
    Asian Pac J Allergy Immunol; 2010 Mar; 28(1):67-75. PubMed ID: 20527519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum anti-neuraminidase antibody responses in human influenza A(H1N1)pdm09 virus infections.
    Karunarathna HMTK; Perera RAPM; Fang VJ; Yen HL; Cowling BJ; Peiris M
    Emerg Microbes Infect; 2019; 8(1):404-412. PubMed ID: 30898033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between Hemagglutinin Stem-Reactive Antibodies and Influenza A/H1N1 Virus Infection during the 2009 Pandemic.
    Hoa LNM; Mai LQ; Bryant JE; Thai PQ; Hang NLK; Yen NTT; Duong TN; Thoang DD; Horby P; Werheim HFL; Fox A
    J Virol; 2016 Jul; 90(14):6549-6556. PubMed ID: 27170747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.